The blood-brain barrier: structure, function and therapeutic approaches to cross it.
about
Nanomedicine in Central Nervous System (CNS) Disorders: A Present and Future ProspectiveRole of Human Breast Cancer Related Protein versus P-Glycoprotein as an Efflux Transporter for Benzylpenicillin: Potential Importance at the Blood-Brain BarrierSafety Evaluation of CNS Administered Biologics-Study Design, Data Interpretation, and Translation to the Clinic.Atypical bromethalin intoxication in a dog: pathologic features and identification of an isomeric breakdown product.Intratumoral heterogeneity in glioblastoma: don't forget the peritumoral brain zone.Value of Functionalized Superparamagnetic Iron Oxide Nanoparticles in the Diagnosis and Treatment of Acute Temporal Lobe Epilepsy on MRI.YAP Is a Critical Inducer of SOCS3, Preventing Reactive Astrogliosis.Control of the blood-brain barrier function in cancer cell metastasis.Advances in nanomedicine for the treatment of Alzheimer's and Parkinson's diseases.The long noncoding RNA TUG1 regulates blood-tumor barrier permeability by targeting miR-144Nanoparticulate strategies for the treatment of polyglutamine diseases by halting the protein aggregation process.Nanocarriers for brain specific delivery of anti-retro viral drugs: challenges and achievements.Mitochondrial crisis in cerebrovascular endothelial cells opens the blood-brain barrier.Genetic variants associated with colorectal brain metastases susceptibility and survival.Endoplasmic Reticulum Stress Mediates Methamphetamine-Induced Blood-Brain Barrier Damage.Targeting Malignant Brain Tumors with Antibodies.Knockdown of long non-coding RNA XIST increases blood-tumor barrier permeability and inhibits glioma angiogenesis by targeting miR-137.The application of magnetic nanoparticles for the treatment of brain tumors.Homeostasis of the Intraparenchymal-Blood Glutamate Concentration Gradient: Maintenance, Imbalance, and Regulation.Micellar formulations of Crizotinib and Dasatinib in the management of glioblastoma multiforme.VEGF-mediated tight junctions pathological fenestration enhances doxorubicin-loaded glycolipid-like nanoparticles traversing BBB for glioblastoma-targeting therapy.In Vitro Microfluidic Models for Neurodegenerative Disorders.A novel IL-1RA-PEP fusion protein alleviates blood-brain barrier disruption after ischemia-reperfusion in male rats.Intranasal Administration of TAT-Conjugated Lipid Nanocarriers Loading GDNF for Parkinson's Disease.Use of PEGylated Immunoliposomes to Deliver Dopamine Across the Blood-Brain Barrier in a Rat Model of Parkinson's Disease.Kudiezi Injection(®) Alleviates Blood-Brain Barrier Disruption After Ischemia-Reperfusion in Rats.PIWIL1/piRNA-DQ593109 Regulates the Permeability of the Blood-Tumor Barrier via the MEG3/miR-330-5p/RUNX3 Axis.Current progress and outcomes of clinical trials on using epidermal growth factor receptor-tyrosine kinase inhibitor therapy in non-small cell lung cancer patients with brain metastases.IP-10 Promotes Blood-Brain Barrier Damage by Inducing Tumor Necrosis Factor Alpha Production in Japanese Encephalitis.
P2860
Q28075999-A91D9053-0597-4A96-8BE3-D921C00A81BEQ28550262-BD007E50-8194-4FC0-B495-67A779C132F8Q31111228-31138192-3A73-49D1-8580-99300CBEE272Q35792193-B992C5B4-34FE-4381-BF6D-9C68C898046DQ36082516-A55542F0-0A81-4EE0-9DC1-67739432A568Q36564626-F08F893F-9178-40C9-B974-08C4BAE2A903Q36794411-CF87409B-C948-43E0-828B-A7C34CCAFD67Q38511670-8F150BCC-263B-4FD1-AECB-1FB42D76A390Q38808008-EEFE9F6D-A500-46FD-A628-FEC690CAABBFQ38863697-8D8E5C76-72C8-4476-8DA9-1CD83127C2AEQ39112084-7F8AD0DC-8D63-46E0-9F45-6036718B2105Q40060003-988C2A1F-6CD1-449D-BA12-9BD3AAEC2A30Q40214443-9BA321F0-8D05-40E4-AE60-00AACD65C420Q41032563-2886BB3F-6A00-47E9-8555-CD24F2961713Q41673313-E342086D-44F1-49A5-B250-A0AC73A9E8F2Q42267793-27725A28-F310-4A5A-97F1-ADF5F94331C6Q42339290-0EC8C968-692A-444E-B04A-C3E748185D66Q43052930-EF77E4AB-0F24-4CD9-886E-490F1F99055AQ47119481-796A4780-EC37-4FC2-91E5-1D29C37C4657Q47292301-04B96AA9-E9B4-4DE1-81D6-63C63613F163Q47357133-157427FE-E260-4F76-AD3F-F46DD33F1C85Q47704356-C34F9D48-342C-4479-82BD-1C7636BCB801Q47863952-5A66C550-37EE-44B4-9FF6-33917774F476Q48129166-2210CEA4-409A-4553-9B8B-7EEFEC3FB01DQ48652783-D7383AED-3EBE-4ADE-A0D0-A1993BD3FFB1Q48748595-94C38369-52D5-4293-A76A-67E145EECFECQ52369044-93CCAC3D-5444-42C7-96A6-6D804BF25E5BQ52709759-FC48AFDB-3EF0-4F6D-AF3A-14ACD2D34702Q55318118-C19B0C53-867D-4FC3-8736-480E3E90D913
P2860
The blood-brain barrier: structure, function and therapeutic approaches to cross it.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
The blood-brain barrier: structure, function and therapeutic approaches to cross it.
@en
type
label
The blood-brain barrier: structure, function and therapeutic approaches to cross it.
@en
prefLabel
The blood-brain barrier: structure, function and therapeutic approaches to cross it.
@en
P2093
P2860
P1476
The blood-brain barrier: structure, function and therapeutic approaches to cross it
@en
P2093
Bertrán Salvador
Biuse Guivernau
Eva Ramos-Fernández
Francisco J Muñoz
Jaume Roquer
Marta Tajes
Mònica Bosch-Morató
Xian Weng-Jiang
P2860
P304
P356
10.3109/09687688.2014.937468
P577
2014-07-21T00:00:00Z